← FDA Drug Approvals (Drugs@FDA)
SPEVIGO
BLA · Biologics License Application · Sponsor: BOEHRINGER INGELHEIM PHARMACEUTICALS INC · Approved 2022-09-01
Drug application
- FDA Application #
BLA761244- Application type
- Biologics License Application
- Brand name
- SPEVIGO
- Generic name
- SPESOLIMAB-SBZO
- Active ingredients
- SPESOLIMAB-SBZO
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- BOEHRINGER INGELHEIM PHARMACEUTICALS INC
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- First approval
- 2022-09-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown